Ampersand Health is a behavioural health and real world data company working in oncology, immunology and inflammation. The company helps people living with complex LTCs find their way to living well, through whole person interventions and predictive health analytics; and provides actionable insights into the patient journey to HCPs and researchers at over 30 institutions in the US and the UK. The company is a spinout from two leading London teaching hospitals and is backed by several specialist investors, including NCL Technology Ventures, Watersedge Capital, Crista Galli Ventures and SimplyHealth Ventures.